DRUG DESIGN DEVELOPMENT AND THERAPY, cilt.13, ss.13-21, 2019 (SCI İndekslerine Giren Dergi)
Introduction and aim: Methotrexate (Mtx) is an antineoplastic and immunosuppressive drug that may cause hepatotoxicity, whereas molsidomine (Mol) is a vasodilating and antioxidant agent. This study aimed to investigate the potential protective effects of Mol in Mtx-induced liver toxicity in rats.